Reflux esophagitis is a chronic and refractory common disease.Western medicine usually adopts symptomatic treatment,which has a high recurrence rate and requires long-term or even life-long treatment.A large number of...Reflux esophagitis is a chronic and refractory common disease.Western medicine usually adopts symptomatic treatment,which has a high recurrence rate and requires long-term or even life-long treatment.A large number of clinical studies have shown that TCM has a significant effect in treating reflux esophagitis.Among them,Xuanfu Daizhe Decoction is a classic prescription that is widely used.This article reviews the aspects of simple prescription treatment,combined treatment of TCM prescriptions,combined treatment of TCM and Western,other related treatments,and microcosmic research of regulating the body by the prescription,so as to provide reference for the further study on improving the treatment of reflux esophagitis with Xuanfu Daizhe Decoction and other drugs.展开更多
Objective: the patients with gastroesophageal reflux were treated with Xuanfu Daizhe decoction combined with Rabeprazole, and the specific application effect of the treatment was analyzed. Methods: the study period of...Objective: the patients with gastroesophageal reflux were treated with Xuanfu Daizhe decoction combined with Rabeprazole, and the specific application effect of the treatment was analyzed. Methods: the study period of this study was from January 2019 to January 2020, and the specific subjects were 40 patients with gastroesophageal reflux admitted to our hospital. For these 40 patients, the grouping method chosen in this paper is digital randomization, which is divided into research group and control group. The control group is treated with rabeprazole enteric capsule, while the research group is treated with Xuanfu Daizhe decoction on the basis of the treatment of the control group. The treatment effect of two groups of patients was analyzed and recorded. Results: in terms of therapeutic efficacy, the improvement degree of the study group was more significant, P < 0.05, the difference was statistically significant. In addition, the TCM syndrome score index results of the two groups were analyzed, and the results showed that the data of the study group was better than that of the other group, while the data at this time showed P < 0.05, indicating that it was statistically significant. Finally, the adverse reactions occurred in different groups after treatment were observed, and it was found that the adverse reaction rate in the study group was relatively lower, so the difference was statistically significant in this study (P > 0.05). Conclusion: the application of Xuanfu Daizhe decoction combined with rabeprazole in the treatment of patients with gastroesophageal reflux can have obvious therapeutic effects, which is worthy of scientific research and clinical promotion.展开更多
基金National Natural Science Foundation of China(No.81460713)Huang Guihua Guangxi Famous Traditional Chinese Medicine Inheritance Studio Project[No.(2017)2]。
文摘Reflux esophagitis is a chronic and refractory common disease.Western medicine usually adopts symptomatic treatment,which has a high recurrence rate and requires long-term or even life-long treatment.A large number of clinical studies have shown that TCM has a significant effect in treating reflux esophagitis.Among them,Xuanfu Daizhe Decoction is a classic prescription that is widely used.This article reviews the aspects of simple prescription treatment,combined treatment of TCM prescriptions,combined treatment of TCM and Western,other related treatments,and microcosmic research of regulating the body by the prescription,so as to provide reference for the further study on improving the treatment of reflux esophagitis with Xuanfu Daizhe Decoction and other drugs.
文摘Objective: the patients with gastroesophageal reflux were treated with Xuanfu Daizhe decoction combined with Rabeprazole, and the specific application effect of the treatment was analyzed. Methods: the study period of this study was from January 2019 to January 2020, and the specific subjects were 40 patients with gastroesophageal reflux admitted to our hospital. For these 40 patients, the grouping method chosen in this paper is digital randomization, which is divided into research group and control group. The control group is treated with rabeprazole enteric capsule, while the research group is treated with Xuanfu Daizhe decoction on the basis of the treatment of the control group. The treatment effect of two groups of patients was analyzed and recorded. Results: in terms of therapeutic efficacy, the improvement degree of the study group was more significant, P < 0.05, the difference was statistically significant. In addition, the TCM syndrome score index results of the two groups were analyzed, and the results showed that the data of the study group was better than that of the other group, while the data at this time showed P < 0.05, indicating that it was statistically significant. Finally, the adverse reactions occurred in different groups after treatment were observed, and it was found that the adverse reaction rate in the study group was relatively lower, so the difference was statistically significant in this study (P > 0.05). Conclusion: the application of Xuanfu Daizhe decoction combined with rabeprazole in the treatment of patients with gastroesophageal reflux can have obvious therapeutic effects, which is worthy of scientific research and clinical promotion.
